Механизмы и причины внезапной сердечной смерти. Факторы и стратификация риска в клинической практике. Основные определения и термины

Автор: Ардашев Андрей Вячеславович, Арутюнов Григорий Павлович, Желяков Евгений Геннадьевич, Беленков Юрий Никитич

Журнал: Клиническая практика @clinpractice

Статья в выпуске: 4 (20), 2014 года.

Бесплатный доступ

Смертность от сердечно-сосудистых заболеваний в России является одной из наиболее высоких в мире и составляет 1462 смертей на 100 000 в год. Основными механизмами драматических исходов сердечно-сосудистых заболеваний являются смерть от прогрессирования хронической сердечной недостаточности и внезапная сердечная смерть (ВСС). Согласно расчетным данным в России от ВСС ежегодно умирает 200 000-250 000 человек.Проблема ВСС является одной из наиболее актуальных для отечественного здравоохранения. Интерес к этому вопросу связан с тем, что ВСС имеет широкую распространенность и тенденцию к росту, а также и тем фактом, что при ВСС существует очевидная возможность использования эффективных профилактических мер.В статье представлены определения, связанные с ВСС, механизмы, основные и второстепенные факторы риска ВСС.

Еще

Внезапная сердечная смерть, желудочковая тахикардия, фибрилляция желудочков, факторы риска внезапной сердечной смерти

Короткий адрес: https://sciup.org/14338505

IDR: 14338505

Список литературы Механизмы и причины внезапной сердечной смерти. Факторы и стратификация риска в клинической практике. Основные определения и термины

Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98:2334-51.
Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:1064-1108.
Шляхто В, Арутюнов, Беленков Ю.Н. и др. Национальные Рекомендации по определению риска и профилактике внезапной сердечной смерти. 2012 г.
Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151-9.
Leclercq JF, Coumel P, Maison-Blanche P, et al. . Arch Mal Coeur Vaiss. 1986; 79(7):1024-33.
Panidis IP, Morganroth J. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983;2(5):798-805.
Mehta D, Curwin J, Gomes JA, Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation 1997; 96: 3215-23.
Roger VL, Go A, Lloyd-Jones DM, et al. Оn behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics 2012 Update: A Report From the American Heart Association Circulation 2012; 125:e2-e220.
Gillum RF. Sudden death in the United States: 1980"1985. Circulation 1989; 79:756-65.
Bigger JT Jr. Identification of patients at high risk for sudden cardiac death. Am J Cardiol. 1984; 54(9):3D-8D.
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337(22): 1576-83.
Connolly S., Gent M., Roberts R., et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable defibrillator against amiodarone. Circulation 2000; 101(11):1297-302.
Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation 2000;102:748-54.
Camm AJ, Julian D, Janse G, et al. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators. Am J Cardiol 1993; 72(16):95F-98F.
Cairns JA, Connolly SJ, Roberts R, Gent M. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators. Am J Cardiol. 1993; 72(16):87F-94F.
Olesen RM, Thomsen PE, Saermark K, Glikson M, et al. Statistical analysis of the DIAMOND MI study by the multipole method. J Physiol Meas 2005; 26(5):591-8.
Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med, 1996; 335:1933-40.
Moss AJ, Zareba W, Hall WJ, et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346:877-83.
Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med, 1999; 341: 1882-90.
Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD"HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-37.
Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med 2002;347:878-85.
Milstein S, Buetikofer J, Lesser J, et al. Cardiac asystole: a manifestation of neutrally mediated hypotension bradycardia. J Am Coll Cardiol 1989;14:1626-32.
Almquist A, Gornick CC, Benson DW, et al. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Circulation 1985;67:927-36.
Ungar A, Del Rosso A, Giada F, et al. Earle and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J 2010;32:2021-6.
Weijenberg MP, Feskens EJ, Kromhout D. Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in elderly men (the Zutphen Elderly Study). J Hypertens 1996;14:1159-66.
Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens Suppl 1991;9:S3-S8.
Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-9.
Staessen JA, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens 1999;13:859-63.
Collins R, Peto R, Mac Mahon S, et al. Blood pressure, stroke, and coronary heart disease. Part2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-38.
Cupples LA, Gagnon DR, Kannel WB. Long-and short-term risk of sudden coronary death. Circulation 1992;85:I11-I18.
Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995; 91:1749-56.
Sexton PT, Walsh J, Jamrozik K, Parsons R. Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust N Z J Med 1997;27:45-50.
Shepherd J, Cobbe SM, FordI et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7.
Burke AP, Farb A, Malcom GT, et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 1999; 281:921-6.
Lemaitre RN, Siscovick DS, Raghunathan TE, et al. Leisure-time physical activity and the risk of primary cardiac arrest. Arch Intern Med 1999; 159:686-90.
Aberg H, Lithell H, Selinus I, Hedstrand H. Alcohol in temperance and social disability as risk factors for different causes of death. Acta Med Scand 1986; 220:351-9.
Dekker JM, Schouten EG, Klootwijk P, et al. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997;145:899-908.
Curb JD, Rodriguez BL, Burchfiel CM, et al. Sudden death, impaired glucose tolerance, and diabetesin Japanese American men. Circulation 1995; 91:2591-5.
Suhonen O, Reunanen A, Knekt P, Aromaa A. Risk factors for sudden and non-sudden coronary death. Acta Med Scand 1988;223:19-25.
deBruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998; 97:467-72.
Manttari M, Oikarinen L, ManninenV, Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997;78:268-72.
Fogoros R.N. Electrophysiologic Testing, 4-th edition. Wiley-Blackwell. 2006. 304 p.

Еще

Статья научная